CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I/II Study of MM-398 in Combination With Ramucirumab After Platinum Failure in Gastric Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03739801
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:45.949295+00:00
- Published At
- 2020-03-27T00:00:00+00:00
- Record Updated At
- 2020-03-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Locally Advanced Unresectable Gastric Adenocarcinoma", "Metastatic Gastroesophageal Junction Adenocarcinoma", "Metastatic Unresectable Gastric Adenocarcinoma", "Unresectable Gastroesophageal Junction Adenocarcinoma", "Gastric Adenocarcinoma", "Gastroesophageal Junction Adenocarcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-27"- protocolSection.identificationModule.nctId
"NCT03739801"- protocolSection.identificationModule.officialTitle
"Phase I/II Study of MM-398 in Combination With Ramucirumab After Platinum Failure in Gastric Cancer"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.